Medpace Holdings Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Net Income	491.5	451.12	404.39	282.81	245.37	181.85
Depreciation & Amortization	27.8	28.12	29.25	26.33	22.34	21.12
Stock-Based Compensation	21.21	34.79	25.51	20.52	21.41	14.47
Other Adjustments	91.87	102.91	-7.52	-2.77	-7.13	-20.82
Change in Receivables	-63.6	-106.22	2.24	-48.28	-66.92	-24.98
Changes in Accounts Payable	-9.44	2.63	-2.97	1.05	6.43	1.87
Changes in Accrued Expenses	128.55	97.08	16.88	82.08	52.48	26.16
Changes in Unearned Revenue	95.94	143.81	150.73	97.13	118.09	88.98
Changes in Other Operating Activities	-31.17	-41.02	-9.7	-25.49	-4.02	-25.31
Operating Cash Flow	752.66	713.22	608.82	433.37	388.05	263.33
Operating Cash Flow Growth	22.56%	17.15%	40.48%	11.68%	47.36%	1.80%
Capital Expenditures	-45.97	-31.36	-36.55	-36.65	-36.88	-28.27
Other Investing Activities	0.21	0.22	8.24	2.02	-1.86	-3.09
Investing Cash Flow	-45.77	-31.14	-28.31	-34.63	-38.74	-31.36
Short-Term Debt Issued	-	-	-	105	324.2	-
Short-Term Debt Repaid	-	-	-	-155	-274.2	-
Net Short-Term Debt Issued (Repaid)	-	-	-	-50	50	-
Issuance of Common Stock	49.81	57	15.86	11.38	22.07	17.64
Repurchase of Common Stock	-299.34	-917.39	-169.87	-144.02	-847.85	-62.1
Net Common Stock Issued (Repurchased)	-249.53	-860.39	-154.01	-132.64	-825.78	-44.45
Financing Cash Flow	-249.53	-860.39	-154.01	-182.64	-775.78	-44.45
Effect of Exchange Rate Changes on Cash and Cash Equivalents	-1.01	5.92	-2.51	1.08	-6.57	-3.97
Net Cash Flow	456.36	-172.39	423.99	217.18	-433.04	183.54
Free Cash Flow	706.69	681.87	572.27	396.73	351.17	235.06
Free Cash Flow Growth	3.64%	19.15%	44.25%	12.97%	49.40%	3.40%
FCF Margin	25.40%	26.95%	27.13%	21.04%	24.05%	20.58%
Free Cash Flow Per Share	24.52	23.09	17.88	12.46	10.43	6.24
Levered Free Cash Flow	657.2	650.38	552.03	377.26	453.81	266.39
Unlevered Free Cash Flow	644.47	644.19	527.34	428.22	400.19	263.47

SEC Filings: 10-K · 10-Q